Part 1
Part 2
Part 3
Part 5
Description
Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease. Due to the COVID-19 pandemic, the global Rheumatoid Arthritis Testing market size was US$ 2008.4 million in 2022 and is forecast to a readjusted size of US$ 3487 million by 2029 with a CAGR of 7.0% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Serological Tests accounting for % of the Rheumatoid Arthritis Testing global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%. The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Rheumatoid Arthritis Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Rheumatoid Arthritis Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Rheumatoid Arthritis Testing market. Readers of the report can become informed about current and future trends of the global Rheumatoid Arthritis Testing market and how they will impact market growth during the forecast period.
Report Metric
Details
Report Title
Global Rheumatoid Arthritis Testing Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Global Rheumatoid Arthritis Testing Companies Covered
Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, Augurex Life Sciences, Svar Life Science AB, Aviva Systems Biology, Bio-Rad Laboratories, Thermo Fisher Scientific, Microdrop, Werfen, Axis-Shield
Global Rheumatoid Arthritis Testing Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Rheumatoid Arthritis Testing in global and regional level.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheumatoid Arthritis Testing revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Serological Tests
1.2.3 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
1.2.4 Imaging Tests
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Testing Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Rheumatoid Arthritis Testing Market Size (2018-2029)
2.2 Rheumatoid Arthritis Testing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global Rheumatoid Arthritis Testing Market Size by Region (2018-2023)
2.4 Global Rheumatoid Arthritis Testing Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 Rheumatoid Arthritis Testing Countries Ranking by Market Size
3 Rheumatoid Arthritis Testing Competitive by Company
3.1 Global Rheumatoid Arthritis Testing Revenue by Players
3.1.1 Global Rheumatoid Arthritis Testing Revenue by Players (2018-2023)
3.1.2 Global Rheumatoid Arthritis Testing Market Share by Players (2018-2023)
3.2 Global Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Rheumatoid Arthritis Testing Revenue
3.4 Global Rheumatoid Arthritis Testing Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Testing Revenue in 2022
3.5 Global Key Players of Rheumatoid Arthritis Testing Head office and Area Served
3.6 Global Key Players of Rheumatoid Arthritis Testing, Product and Application
3.7 Global Key Players of Rheumatoid Arthritis Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Rheumatoid Arthritis Testing Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Testing Historic Revenue by Type (2018-2023)
4.2 Global Rheumatoid Arthritis Testing Forecasted Revenue by Type (2024-2029)
5 Global Rheumatoid Arthritis Testing Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Testing Historic Market Size by Application (2018-2023)
5.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rheumatoid Arthritis Testing Revenue by Company (2021-2023)
6.2 North America Rheumatoid Arthritis Testing Revenue by Type (2018-2029)
6.3 North America Rheumatoid Arthritis Testing Revenue by Application (2018-2029)
6.4 North America Rheumatoid Arthritis Testing Revenue by Country (2018-2029)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Testing Revenue by Company (2021-2023)
7.2 Europe Rheumatoid Arthritis Testing Revenue by Type (2018-2029)
7.3 Europe Rheumatoid Arthritis Testing Revenue by Application (2018-2029)
7.4 Europe Rheumatoid Arthritis Testing Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Rheumatoid Arthritis Testing Revenue by Company (2021-2023)
8.2 Asia Pacific Rheumatoid Arthritis Testing Revenue by Type (2018-2029)
8.3 Asia Pacific Rheumatoid Arthritis Testing Revenue by Application (2018-2029)
8.4 Asia Pacific Rheumatoid Arthritis Testing Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Testing Revenue by Company (2021-2023)
9.2 Latin America Rheumatoid Arthritis Testing Revenue by Type (2018-2029)
9.3 Latin America Rheumatoid Arthritis Testing Revenue by Application (2018-2029)
9.4 Latin America Rheumatoid Arthritis Testing Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rheumatoid Arthritis Testing Revenue by Company (2021-2023)
10.2 Middle East and Africa Rheumatoid Arthritis Testing Revenue by Type (2018-2029)
10.3 Middle East and Africa Rheumatoid Arthritis Testing Revenue by Application (2018-2029)
10.4 Middle East and Africa Rheumatoid Arthritis Testing Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Products and Services
11.1.4 Abbott Laboratories Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.1.5 Abbott Laboratories Rheumatoid Arthritis Testing SWOT Analysis
11.1.6 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Products and Services
11.2.4 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Rheumatoid Arthritis Testing SWOT Analysis
11.2.6 F. Hoffmann-La Roche Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Rheumatoid Arthritis Testing Products and Services
11.3.4 Beckman Coulter Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.3.5 Beckman Coulter Rheumatoid Arthritis Testing SWOT Analysis
11.3.6 Beckman Coulter Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Products and Services
11.4.4 Siemens Healthineers Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.4.5 Siemens Healthineers Rheumatoid Arthritis Testing SWOT Analysis
11.4.6 Siemens Healthineers Recent Development
11.5 Augurex Life Sciences
11.5.1 Augurex Life Sciences Company Details
11.5.2 Augurex Life Sciences Business Overview
11.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Products and Services
11.5.4 Augurex Life Sciences Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.5.5 Augurex Life Sciences Rheumatoid Arthritis Testing SWOT Analysis
11.5.6 Augurex Life Sciences Recent Development
11.6 Svar Life Science AB
11.6.1 Svar Life Science AB Company Details
11.6.2 Svar Life Science AB Business Overview
11.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Products and Services
11.6.4 Svar Life Science AB Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.6.5 Svar Life Science AB Rheumatoid Arthritis Testing SWOT Analysis
11.6.6 Svar Life Science AB Recent Development
11.7 Aviva Systems Biology
11.7.1 Aviva Systems Biology Company Details
11.7.2 Aviva Systems Biology Business Overview
11.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Products and Services
11.7.4 Aviva Systems Biology Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.7.5 Aviva Systems Biology Rheumatoid Arthritis Testing SWOT Analysis
11.7.6 Aviva Systems Biology Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Products and Services
11.8.4 Bio-Rad Laboratories Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.8.5 Bio-Rad Laboratories Rheumatoid Arthritis Testing SWOT Analysis
11.8.6 Bio-Rad Laboratories Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Products and Services
11.9.4 Thermo Fisher Scientific Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.9.5 Thermo Fisher Scientific Rheumatoid Arthritis Testing SWOT Analysis
11.9.6 Thermo Fisher Scientific Recent Development
11.10 Microdrop
11.10.1 Microdrop Company Details
11.10.2 Microdrop Business Overview
11.10.3 Microdrop Rheumatoid Arthritis Testing Products and Services
11.10.4 Microdrop Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.10.5 Microdrop Rheumatoid Arthritis Testing SWOT Analysis
11.10.6 Microdrop Recent Development
11.11 Werfen
11.11.1 Werfen Company Details
11.11.2 Werfen Business Overview
11.11.3 Werfen Rheumatoid Arthritis Testing Products and Services
11.11.4 Werfen Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.11.5 Werfen Recent Development
11.12 Axis-Shield
11.12.1 Axis-Shield Company Details
11.12.2 Axis-Shield Business Overview
11.12.3 Axis-Shield Rheumatoid Arthritis Testing Products and Services
11.12.4 Axis-Shield Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023)
11.12.5 Axis-Shield Recent Development
12 Rheumatoid Arthritis Testing Market Dynamics
12.1 Rheumatoid Arthritis Testing Industry Trends
12.2 Rheumatoid Arthritis Testing Market Drivers
12.3 Rheumatoid Arthritis Testing Market Challenges
12.4 Rheumatoid Arthritis Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
Table of Figures
List of Tables
Table 1. Global Rheumatoid Arthritis Testing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Serological Tests
Table 3. Key Players of Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Table 4. Key Players of Imaging Tests
Table 5. Key Players of Others
Table 6. Global Rheumatoid Arthritis Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Rheumatoid Arthritis Testing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 8. Global Rheumatoid Arthritis Testing Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Rheumatoid Arthritis Testing Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 10. Global Rheumatoid Arthritis Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 11. Global Rheumatoid Arthritis Testing Revenue by Players (2018-2023) & (US$ Million)
Table 12. Global Rheumatoid Arthritis Testing Market Share by Players (2018-2023)
Table 13. Global Top Rheumatoid Arthritis Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2022)
Table 14. Ranking of Global Top Rheumatoid Arthritis Testing Companies by Revenue (US$ Million) in 2022
Table 15. Global 5 Largest Players Market Share by Rheumatoid Arthritis Testing Revenue (CR5 and HHI) & (2018-2023)
Table 16. Global Key Players of Rheumatoid Arthritis Testing, Headquarters and Area Served
Table 17. Global Key Players of Rheumatoid Arthritis Testing, Product and Application
Table 18. Global Key Players of Rheumatoid Arthritis Testing, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Rheumatoid Arthritis Testing Market Size by Type (2018-2023) & (US$ Million)
Table 21. Global Rheumatoid Arthritis Testing Revenue Market Share by Type (2018-2023)
Table 22. Global Rheumatoid Arthritis Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 23. Global Rheumatoid Arthritis Testing Revenue Market Share by Type (2024-2029)
Table 24. Global Rheumatoid Arthritis Testing Market Size by Application (2018-2023) & (US$ Million)
Table 25. Global Rheumatoid Arthritis Testing Revenue Market Share by Application (2018-2023)
Table 26. Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 27. Global Rheumatoid Arthritis Testing Revenue Market Share by Application (2024-2029)
Table 28. North America Rheumatoid Arthritis Testing Revenue by Company (2021-2023) & (US$ Million)
Table 29. North America Rheumatoid Arthritis Testing Revenue by Type (2018-2023) & (US$ Million)
Table 30. North America Rheumatoid Arthritis Testing Revenue by Type (2024-2029) & (US$ Million)
Table 31. North America Rheumatoid Arthritis Testing Revenue by Application (2018-2023) & (US$ Million)
Table 32. North America Rheumatoid Arthritis Testing Revenue by Application (2024-2029) & (US$ Million)
Table 33. North America Rheumatoid Arthritis Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Rheumatoid Arthritis Testing Revenue by Country (2018-2023) & (US$ Million)
Table 35. North America Rheumatoid Arthritis Testing Revenue by Country (2024-2029) & (US$ Million)
Table 36. Europe Rheumatoid Arthritis Testing Revenue by Company (2021-2023) & (US$ Million)
Table 37. Europe Rheumatoid Arthritis Testing Revenue by Type (2018-2023) & (US$ Million)
Table 38. Europe Rheumatoid Arthritis Testing Revenue by Type (2024-2029) & (US$ Million)
Table 39. Europe Rheumatoid Arthritis Testing Revenue by Application (2018-2023) & (US$ Million)
Table 40. Europe Rheumatoid Arthritis Testing Revenue by Application (2024-2029) & (US$ Million)
Table 41. Europe Rheumatoid Arthritis Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Europe Rheumatoid Arthritis Testing Revenue by Country (2018-2023) & (US$ Million)
Table 43. Europe Rheumatoid Arthritis Testing Revenue by Country (2024-2029) & (US$ Million)
Table 44. Asia Pacific Rheumatoid Arthritis Testing Revenue by Company (2021-2023) & (US$ Million)
Table 45. Asia Pacific Rheumatoid Arthritis Testing Revenue by Type (2018-2023) & (US$ Million)
Table 46. Asia Pacific Rheumatoid Arthritis Testing Revenue by Type (2024-2029) & (US$ Million)
Table 47. Asia Pacific Rheumatoid Arthritis Testing Revenue by Application (2018-2023) & (US$ Million)
Table 48. Asia Pacific Rheumatoid Arthritis Testing Revenue by Application (2024-2029) & (US$ Million)
Table 49. Asia-Pacific Rheumatoid Arthritis Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 50. Asia Pacific Rheumatoid Arthritis Testing Revenue by Region (2018-2023) & (US$ Million)
Table 51. Asia Pacific Rheumatoid Arthritis Testing Revenue by Region (2024-2029) & (US$ Million)
Table 52. Latin America Rheumatoid Arthritis Testing Revenue by Company (2021-2023) & (US$ Million)
Table 53. Latin America Rheumatoid Arthritis Testing Revenue by Type (2018-2023) & (US$ Million)
Table 54. Latin America Rheumatoid Arthritis Testing Revenue by Type (2024-2029) & (US$ Million)
Table 55. Latin America Rheumatoid Arthritis Testing Revenue by Application (2018-2023) & (US$ Million)
Table 56. Latin America Rheumatoid Arthritis Testing Revenue by Application (2024-2029) & (US$ Million)
Table 57. Latin America Rheumatoid Arthritis Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 58. Latin America Rheumatoid Arthritis Testing Revenue by Country (2018-2023) & (US$ Million)
Table 59. Latin America Rheumatoid Arthritis Testing Revenue by Country (2024-2029) & (US$ Million)
Table 60. Middle East and Africa Rheumatoid Arthritis Testing Revenue by Company (2021-2023) & (US$ Million)
Table 61. Middle East and Africa Rheumatoid Arthritis Testing Revenue by Type (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Rheumatoid Arthritis Testing Revenue by Type (2024-2029) & (US$ Million)
Table 63. Middle East and Africa Rheumatoid Arthritis Testing Revenue by Application (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Rheumatoid Arthritis Testing Revenue by Application (2024-2029) & (US$ Million)
Table 65. Middle East and Africa Rheumatoid Arthritis Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East and Africa Rheumatoid Arthritis Testing Revenue by Country (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Rheumatoid Arthritis Testing Revenue by Country (2024-2029) & (US$ Million)
Table 68. Abbott Laboratories Company Details
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Rheumatoid Arthritis Testing Product and Services
Table 71. Abbott Laboratories Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 72. Abbott Laboratories Rheumatoid Arthritis Testing SWOT Analysis
Table 73. Abbott Laboratories Recent Development
Table 74. F. Hoffmann-La Roche Company Details
Table 75. F. Hoffmann-La Roche Business Overview
Table 76. F. Hoffmann-La Roche Rheumatoid Arthritis Testing Product and Services
Table 77. F. Hoffmann-La Roche Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 78. F. Hoffmann-La Roche Rheumatoid Arthritis Testing SWOT Analysis
Table 79. F. Hoffmann-La Roche Recent Development
Table 80. Beckman Coulter Company Details
Table 81. Beckman Coulter Business Overview
Table 82. Beckman Coulter Rheumatoid Arthritis Testing Product and Services
Table 83. Beckman Coulter Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 84. Beckman Coulter Rheumatoid Arthritis Testing SWOT Analysis
Table 85. Beckman Coulter Recent Development
Table 86. Siemens Healthineers Company Details
Table 87. Siemens Healthineers Business Overview
Table 88. Siemens Healthineers Rheumatoid Arthritis Testing Product and Services
Table 89. Siemens Healthineers Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 90. Siemens Healthineers Rheumatoid Arthritis Testing SWOT Analysis
Table 91. Siemens Healthineers Recent Development
Table 92. Augurex Life Sciences Company Details
Table 93. Augurex Life Sciences Business Overview
Table 94. Augurex Life Sciences Rheumatoid Arthritis Testing Product and Services
Table 95. Augurex Life Sciences Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 96. Augurex Life Sciences Rheumatoid Arthritis Testing SWOT Analysis
Table 97. Augurex Life Sciences Recent Development
Table 98. Svar Life Science AB Company Details
Table 99. Svar Life Science AB Business Overview
Table 100. Svar Life Science AB Rheumatoid Arthritis Testing Product and Services
Table 101. Svar Life Science AB Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 102. Svar Life Science AB Rheumatoid Arthritis Testing SWOT Analysis
Table 103. Svar Life Science AB Recent Development
Table 104. Aviva Systems Biology Company Details
Table 105. Aviva Systems Biology Business Overview
Table 106. Aviva Systems Biology Rheumatoid Arthritis Testing Product and Services
Table 107. Aviva Systems Biology Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 108. Aviva Systems Biology Rheumatoid Arthritis Testing SWOT Analysis
Table 109. Aviva Systems Biology Recent Development
Table 110. Bio-Rad Laboratories Company Details
Table 111. Bio-Rad Laboratories Business Overview
Table 112. Bio-Rad Laboratories Rheumatoid Arthritis Testing Product and Services
Table 113. Bio-Rad Laboratories Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 114. Bio-Rad Laboratories Rheumatoid Arthritis Testing SWOT Analysis
Table 115. Bio-Rad Laboratories Recent Development
Table 116. Thermo Fisher Scientific Company Details
Table 117. Thermo Fisher Scientific Business Overview
Table 118. Thermo Fisher Scientific Rheumatoid Arthritis Testing Product and Services
Table 119. Thermo Fisher Scientific Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 120. Thermo Fisher Scientific Rheumatoid Arthritis Testing SWOT Analysis
Table 121. Thermo Fisher Scientific Recent Development
Table 122. Microdrop Company Details
Table 123. Microdrop Business Overview
Table 124. Microdrop Rheumatoid Arthritis Testing Product and Services
Table 125. Microdrop Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 126. Microdrop Rheumatoid Arthritis Testing SWOT Analysis
Table 127. Microdrop Recent Development
Table 128. Werfen Company Details
Table 129. Werfen Business Overview
Table 130. Werfen Rheumatoid Arthritis Testing Product and Services
Table 131. Werfen Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 132. Werfen Recent Development
Table 133. Axis-Shield Company Details
Table 134. Axis-Shield Business Overview
Table 135. Axis-Shield Rheumatoid Arthritis Testing Product and Services
Table 136. Axis-Shield Rheumatoid Arthritis Testing Revenue in Rheumatoid Arthritis Testing Business (2018-2023) & (US$ Million)
Table 137. Axis-Shield Recent Development
Table 138. Rheumatoid Arthritis Testing Market Trends
Table 139. Rheumatoid Arthritis Testing Market Drivers
Table 140. Rheumatoid Arthritis Testing Market Challenges
Table 141. Rheumatoid Arthritis Testing Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Rheumatoid Arthritis Testing Product Picture
Figure 2. Global Rheumatoid Arthritis Testing Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global Rheumatoid Arthritis Testing Market Share by Type: 2022 VS 2029
Figure 4. Serological Tests Features
Figure 5. Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests Features
Figure 6. Imaging Tests Features
Figure 7. Others Features
Figure 8. Global Rheumatoid Arthritis Testing Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 9. Global Rheumatoid Arthritis Testing Market Share by Application: 2022 VS 2029
Figure 10. Hospitals and Clinics
Figure 11. Diagnostic Centers
Figure 12. Others
Figure 13. Rheumatoid Arthritis Testing Report Years Considered
Figure 14. Global Rheumatoid Arthritis Testing Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Rheumatoid Arthritis Testing Market Size 2018-2029 (US$ Million)
Figure 16. Global Rheumatoid Arthritis Testing Market Size Market Share by Region: 2022 VS 2029
Figure 17. Global Rheumatoid Arthritis Testing Revenue Market Share by Region in 2018 VS 2022
Figure 18. Global Rheumatoid Arthritis Testing Revenue Market Share Forecast by Region (2024-2029)
Figure 19. Global Top 10 Rheumatoid Arthritis Testing Countries Ranking by Market Size (US$ Million) in 2022
Figure 20. Global Rheumatoid Arthritis Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 21. Global Rheumatoid Arthritis Testing Market Share by Players in 2022
Figure 22. Global Top Rheumatoid Arthritis Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis Testing Revenue in 2022
Figure 24. North America Rheumatoid Arthritis Testing Revenue Market Share by Company in 2022
Figure 25. North America Rheumatoid Arthritis Testing Revenue Market Share by Type (2018-2029)
Figure 26. North America Rheumatoid Arthritis Testing Revenue Market Share by Application (2018-2029)
Figure 27. North America Rheumatoid Arthritis Testing Revenue Share by Country (2018-2029)
Figure 28. United States Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 29. Canada Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 30. Europe Rheumatoid Arthritis Testing Revenue Market Share by Company in 2022
Figure 31. Europe Rheumatoid Arthritis Testing Revenue Market Share by Type (2018-2029)
Figure 32. Europe Rheumatoid Arthritis Testing Revenue Market Share by Application (2018-2029)
Figure 33. Europe Rheumatoid Arthritis Testing Revenue Share by Country (2018-2029)
Figure 34. Germany Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 35. France Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 36. U.K. Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 37. Italy Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 38. Russia Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Rheumatoid Arthritis Testing Revenue Market Share by Company in 2022
Figure 40. Asia Pacific Rheumatoid Arthritis Testing Revenue Market Share by Type (2018-2029)
Figure 41. Asia Pacific Rheumatoid Arthritis Testing Revenue Market Share by Application (2018-2029)
Figure 42. Asia Pacific Rheumatoid Arthritis Testing Revenue Share by Region (2018-2029)
Figure 43. China Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 44. Japan Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 45. South Korea Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 46. India Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 47. Australia Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 48. China Taiwan Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 49. Indonesia Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 50. Thailand Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 51. Malaysia Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 52. Latin America Rheumatoid Arthritis Testing Revenue Market Share by Company in 2022
Figure 53. Latin America Rheumatoid Arthritis Testing Revenue Market Share by Type (2018-2029)
Figure 54. Latin America Rheumatoid Arthritis Testing Revenue Market Share by Application (2018-2029)
Figure 55. Latin America Rheumatoid Arthritis Testing Revenue Share by Country (2018-2029)
Figure 56. Mexico Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 57. Brazil Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 58. Argentina Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 59. Middle East and Africa Rheumatoid Arthritis Testing Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa Rheumatoid Arthritis Testing Revenue Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Rheumatoid Arthritis Testing Revenue Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Rheumatoid Arthritis Testing Revenue Share by Country (2018-2029)
Figure 63. Turkey Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 64. Saudi Arabia Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 65. UAE Rheumatoid Arthritis Testing Revenue (2018-2029) & (US$ Million)
Figure 66. Abbott Laboratories Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 67. F. Hoffmann-La Roche Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 68. Beckman Coulter Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 69. Siemens Healthineers Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 70. Augurex Life Sciences Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 71. Svar Life Science AB Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 72. Aviva Systems Biology Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 73. Bio-Rad Laboratories Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 74. Thermo Fisher Scientific Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 75. Microdrop Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 76. Werfen Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 77. Axis-Shield Revenue Growth Rate in Rheumatoid Arthritis Testing Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Description
Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease. Due to the COVID-19 pandemic, the global Rheumatoid Arthritis Testing market size was US$ 2008.4 million in 2022 and is forecast to a readjusted size of US$ 3487 million by 2029 with a CAGR of 7.0% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Serological Tests accounting for % of the Rheumatoid Arthritis Testing global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%. The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Rheumatoid Arthritis Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Rheumatoid Arthritis Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Rheumatoid Arthritis Testing market. Readers of the report can become informed about current and future trends of the global Rheumatoid Arthritis Testing market and how they will impact market growth during the forecast period.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Rheumatoid Arthritis Testing in global and regional level.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheumatoid Arthritis Testing revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now